These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis. Palacios S Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824 [TBL] [Abstract][Full Text] [Related]
3. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis. Genant HK Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498 [TBL] [Abstract][Full Text] [Related]
4. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis. Kung AW; Chu EY; Xu L Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene]. Chaki O Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091 [TBL] [Abstract][Full Text] [Related]
6. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex. Pickar JH; Mirkin S Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. Silverman SL; Christiansen C; Genant HK; Vukicevic S; Zanchetta JR; de Villiers TJ; Constantine GD; Chines AA J Bone Miner Res; 2008 Dec; 23(12):1923-34. PubMed ID: 18665787 [TBL] [Abstract][Full Text] [Related]
9. [Bazedoxifene as a new-generation SERM]. Ohta H Clin Calcium; 2011 Jan; 21(1):34-42. PubMed ID: 21187592 [TBL] [Abstract][Full Text] [Related]
10. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related]
11. Use of SERMs for treatment in postmenopausal women. Pinkerton JV; Thomas S J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794 [TBL] [Abstract][Full Text] [Related]
12. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? Sambrook P Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191 [TBL] [Abstract][Full Text] [Related]
13. Bazedoxifene acetate: a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis. Chines AA; Komm BS Drugs Today (Barc); 2009 Jul; 45(7):507-20. PubMed ID: 19834628 [TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis. de Villiers TJ Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423 [TBL] [Abstract][Full Text] [Related]